Ten Campus Clínic projects receive funding from La Marató de 3Cat for cancer research
Ten projects involving researchers from Campus Clínic, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), have been se...
Ten projects involving researchers from Campus Clínic, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), have been se...
A study led by the IDIBAPS Systems Neuroscience research group has demonstrated that the uneven distribution of certain molecular receptors in the...
The IDIBAPS Executive Committee has approved the creation of the new research group. Ferran Nadeu, an R3B researcher, was previously part of the Mo...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has played a prominent role at the European Society...
A study led by the Bipolar and depressive disorders research group at IDIBAPS concludes that there are inequalities in the mental health of LGBTQI...
The team has identified a non-coding long RNA molecule, called LINC00152, that could play a key role in the development of resistance to treatments...
The Clínic Barcelona Comprehensive Cancer Centre (4CB) has appointed Dr Susana Puig as Director of Research and Dr Teresa Macarulla as Director of...
The institute is the leading Catalan centre of excellence in biomedical research in terms of funding awarded, securing more than €38.5 million over...
This initiative by Institució CERCA recognizes recently defended doctoral theses with the greatest potential for transfer to the market and society.
A large international study, led by the Clínic-IDIBAPS, the European Foundation for the Study of Chronic Liver Disease (EF CLIF), the Hôpital Unive...